
Join to view full profile
1211 Medical Center DrNashville, TN 37232
Phone+1 615-322-5000
Dr. Wilfong is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2016 - 2020
University of California (San Francisco)Fellowship, Rheumatology, 2014 - 2016
Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2014
Duke University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2014 - 2028
TN State Medical License 2017 - 2027
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- SGLT2 Inhibitor Empagliflozin Reduces Circulating Monocyte-Platelet Aggregates: A Pilot Study.B Ilkin Safa, Jared M Oakes, Joshua D Simmons, Hui Nian, Leslie A Kirk
Circulation. 2026-09-15 - Multiomic analysis identifies T cell subsets and mechanisms of epithelial interaction in idiopathic pulmonary fibrosis.Ana Pm Serezani, Julia Mr Bazzano, Bruno D Pascoalino, Ludmilla da Silva, Abigail J Dietrich
JCI Insight. 2026-09-08 - Chimeric Antigen Receptor T-Cell Therapy in Autoimmune Disorders: An Expert Panel Opinion From the American Society for Transplantation and Cellular Therapy.Olalekan O Oluwole, Leslie Crofford, Andrew P Jallouk, Daniel W Lee, Rebecca Gardner
Transplantation and Cellular Therapy. 2026-09-01
Journal Articles
- Effects of Bone Marrow‐Derived Mesenchymal Stromal Cells on Gene Expression in Human Alveolar Type II Cells Exposed to TNF‐Α, IL‐1β, and IFN‐ΓErin Wilfong, MD, Physiological Reports
- Interstitial Pneumonia with Autoimmune Features: An Emerging Challenge at the Intersection of Rheumatology and PulmonologyRobert J Lentz, Peggy L Kendall, Leslie J Crofford, James J Tolle, Adam Guttentag, Timothy S Blackwell, Joyce E Johnson, Erin M Wilfong, Jonathan A Kropski, Arthritis & Rheumatology
Press Mentions
New Insights into Managing Interstitial Lung DiseaseNovember 18th, 2025- Pearls from an Expert: Challenging ILD Cases with a Pulmonologist-RheumatologistJune 17th, 2022
COVID-19 Met with Intensive TeamworkApril 1st, 2021
Grant Support
- Immunophenotypes in the Idiopathic Inflammatory MyopathiesVANDERBILT UNIVERSITY MEDICAL CENTER2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: